Paige M Estave1, Marie L Jacobs1, Margaret Rukstalis2, Jon Goforth1, Shane N Stone3, Jungbin A Choi1, Jessica Barrett1, Heather E Douglas4, Jennifer B Oliver5, Michelle K Keating6, Julie A Freischlag7, Mary Claire O'Brien8, Sara McEwen9, Roy E Strowd10. 1. Wake Forest School of Medicine, Winston Salem, NC, USA. 2. University of South Carolina School of Medicine and VAMC, Columbia, SC, USA. 3. Department of Physician Medicine and Rehabilitation, McGaw Medical Center, Northwestern University, Chicago, IL, USA. 4. Department of Psychiatry and Behavioral Medicine, Wake Forest School of Medicine, Winston Salem, NC, USA. 5. Department of Anesthesia, Wake Forest School of Medicine, Winston Salem, NC, USA. 6. Department of Family Medicine, Wake Forest School of Medicine, Winston Salem, NC, USA. 7. Department of Vascular and Endovascular Surgery, Wake Forest School of Medicine, Winston Salem, NC, USA. 8. Department of Emergency Medicine, Wake Forest School of Medicine, Winston Salem, NC, USA. 9. Governor's Institute on Substance Abuse, Raleigh, NC, USA. 10. Department of Neurology, Wake Forest School of Medicine, Winston Salem, NC, USA.
Abstract
Background: With a drastic shortage of addiction medicine specialists-and an ever-growing number of patients with opioid use disorder (OUD)-there is a dire need for more clinicians to feel confident in prevention and management of OUD and obtain a DEA-X waiver to prescribe medications to treat OUD. Here we determine if it is feasible to certify 4th year medical students with DEA-X waiver training as a component of the PROUD (Prevent and Reduce Opioid Use Disorder) curriculum, and if PROUD enhanced preparedness for medical students to manage OUD as interns. Methods: We implemented a sequential mixed-methods IRB approved study to assess feasibility (completing all required components of DEA-X waiver training) and impact of PROUD (measured by knowledge growth, enhancement for residency, and utilization of training during internship). Students completed 11 hours of required OUD training. Quantitative data included pre-/post- knowledge and curriculum satisfaction assessments as well as long-term impact with follow up survey as interns. Qualitative data was collected by survey and semi-structured focus groups. Results: All 120 graduating medical students completed the required components of the curriculum. Knowledge improved on the Provider Clinical Support Services (12.9-17.3, p < 0.0001) and Brief Opioid Overdose Knowledge assessments (10.15-10.81, p < 0.0001). Course satisfaction was high: 90% recommended online modules; 85% recommended training overall. Six qualitative themes emerged: (1) curriculum content was practical, (2) online modules allowed flexibility, (3) in-person seminars ensured authenticity, (4) timing at the transition to residency was optimal, (5) curriculum enhanced awareness and confidence, and (6) training was applicable to future careers. At 3 months, 60% reported using their training during internship; 64% felt more prepared to treat OUD than peers. Conclusions: PROUD trained 4th year medical students in opioid stewardship. As interns, students felt ready to serve as change agents to prevent, diagnose, and treat OUD.
Background: With a drastic shortage of addiction medicine specialists-and an ever-growing number of patients with opioid use disorder (OUD)-there is a dire need for more clinicians to feel confident in prevention and management of OUD and obtain a DEA-X waiver to prescribe medications to treat OUD. Here we determine if it is feasible to certify 4th year medical students with DEA-X waiver training as a component of the PROUD (Prevent and Reduce Opioid Use Disorder) curriculum, and if PROUD enhanced preparedness for medical students to manage OUD as interns. Methods: We implemented a sequential mixed-methods IRB approved study to assess feasibility (completing all required components of DEA-X waiver training) and impact of PROUD (measured by knowledge growth, enhancement for residency, and utilization of training during internship). Students completed 11 hours of required OUD training. Quantitative data included pre-/post- knowledge and curriculum satisfaction assessments as well as long-term impact with follow up survey as interns. Qualitative data was collected by survey and semi-structured focus groups. Results: All 120 graduating medical students completed the required components of the curriculum. Knowledge improved on the Provider Clinical Support Services (12.9-17.3, p < 0.0001) and Brief Opioid Overdose Knowledge assessments (10.15-10.81, p < 0.0001). Course satisfaction was high: 90% recommended online modules; 85% recommended training overall. Six qualitative themes emerged: (1) curriculum content was practical, (2) online modules allowed flexibility, (3) in-person seminars ensured authenticity, (4) timing at the transition to residency was optimal, (5) curriculum enhanced awareness and confidence, and (6) training was applicable to future careers. At 3 months, 60% reported using their training during internship; 64% felt more prepared to treat OUD than peers. Conclusions: PROUD trained 4th year medical students in opioid stewardship. As interns, students felt ready to serve as change agents to prevent, diagnose, and treat OUD.
Entities:
Keywords:
DATA 2000 waiver; MOUD; OUD; buprenorphine; medical education; opioid stewardship; transition to residency
Authors: Hansel E Tookes; Jasmine Tomita-Barber; Sabrina Taldone; Morgan Shane; Matthew R Imm; Henri Ford; Joan St Onge; David W Forrest; Tyler S Bartholomew; David P Serota Journal: MedEdPORTAL Date: 2022-05-24